BioAxone Therapeutic

About:

BioAxone Therapeutic is neuroscience company focused on the development and commercialization of technologies that target Rho signaling.

Website: http://www.bioaxone.com

Top Investors: Fonds de solidarité FTQ, Desjardins Venture Capital, T2C2 Capital, Lothian Partners

Description:

BioAxone Therapeutic operates as a neuroscience company. The company specializes in the development and commercialization of proprietary technologies that target Rho signaling. It provides an experimental therapy for the treatment of neurological disorders. The company's product includes Cethrin for clinical trial for spinal cord injury. BioAxone Therapeutic was founded in 2000 and is based in Saint-Laurent, Canada.